Tasly Pharmaceutical Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001C81
CNY
13.63
-0.52 (-3.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
8,150.08
8,416.63
8,591.34
8,548.40
7,871.24
13,499.29
18,910.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
8,150.08
8,416.63
8,591.34
8,548.40
7,871.24
13,499.29
18,910.73
Raw Material Cost
2,904.12
2,975.70
3,062.63
3,287.52
2,836.87
8,420.50
13,209.80
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
1,388.22
1,474.09
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
34.02
64.80
87.26
69.90
80.96
297.74
463.14
Selling and Distribution Expenses
3,272.04
3,263.64
3,263.92
3,203.15
3,266.10
3,208.58
3,321.88
Other Expenses
54.57
65.25
71.77
67.18
40.63
-123.66
-146.17
Total Expenditure (Excl Depreciation)
6,755.86
6,956.64
7,131.46
7,232.40
6,590.27
12,078.46
17,007.26
Operating Profit (PBDIT) excl Other Income
1394.1999999999998
1460
1459.9
1316
1281
1420.8000000000002
1903.5
Other Income
171.25
137.17
168.77
103.95
767.45
304.64
165.88
Operating Profit (PBDIT)
1,995.94
2,071.93
2,124.34
1,896.80
2,510.22
2,276.60
2,437.00
Interest
34.02
64.80
87.26
69.90
80.96
297.74
463.14
Exceptional Items
104.26
-329.74
-169.81
-1,448.55
914.25
66.33
-118.58
Gross Profit (PBDT)
5,245.96
5,440.93
5,528.72
5,260.88
5,034.38
5,078.79
5,700.93
Depreciation
464.61
502.49
516.14
532.68
502.99
590.04
423.76
Profit Before Tax
1,601.57
1,174.90
1,351.13
-154.33
2,840.51
1,455.15
1,431.51
Tax
283.89
209.63
204.46
180.82
315.92
367.20
327.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,104.96
955.59
1,071.07
-264.24
2,358.86
1,125.89
1,001.42
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,104.96
955.59
1,071.07
-264.24
2,358.86
1,125.89
1,001.42
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-43.63
-96.53
-54.43
-84.22
48.75
-36.03
1.74
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,061.33
859.06
1,016.64
-348.46
2,407.62
1,089.86
1,003.17
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,404.23
11,903.33
12,368.42
12,412.39
12,981.16
11,972.47
11,131.65
Earnings per share (EPS)
0.74
0.64
0.72
-0.18
1.57
0.75
0.66
Diluted Earnings per share
0.74
0.64
0.72
-0.18
1.57
0.75
0.66
Operating Profit Margin (Excl OI)
16.69%
17.02%
16.75%
14.74%
15.75%
10.24%
9.77%
Gross Profit Margin
25.35%
19.93%
21.73%
4.43%
42.48%
15.15%
9.81%
PAT Margin
13.56%
11.35%
12.47%
-3.09%
29.97%
8.34%
5.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -3.17% vs -2.03% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 23.54% vs -15.49% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -5.69% vs -1.06% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -47.53% vs -25.77% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Tasly Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
8,150.08
0
8,150.08
Other Operating Income
0.00
0.00
0.00
Total Operating income
8,150.08
0
8,150.08
Raw Material Cost
2,904.12
0
2,904.12
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
34.02
0
34.02
Selling and Distribution Expenses
3,272.04
0
3,272.04
Other Expenses
54.57
0.00
54.57
Total Expenditure (Excl Depreciation)
6,755.86
0
6,755.86
Operating Profit (PBDIT) excl Other Income
1,394.22
0.00
1,394.22
Other Income
171.25
0
171.25
Operating Profit (PBDIT)
1,995.94
0
1,995.94
Interest
34.02
0
34.02
Exceptional Items
104.26
0
104.26
Gross Profit (PBDT)
5,245.96
0
5,245.96
Depreciation
464.61
0
464.61
Profit Before Tax
1,601.57
0
1,601.57
Tax
283.89
0
283.89
Provisions and contingencies
0
0
0.00
Profit After Tax
1,104.96
0
1,104.96
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,104.96
0
1,104.96
Share in Profit of Associates
0
0
0.00
Minority Interest
-43.63
0
-43.63
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,061.33
0
1,061.33
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
12,404.23
0
12,404.23
Earnings per share (EPS)
0.74
0
0.74
Diluted Earnings per share
0.74
0
0.74
Operating Profit Margin (Excl OI)
16.69%
0%
0.00
16.69%
Gross Profit Margin
25.35%
0%
0.00
25.35%
PAT Margin
13.56%
0%
0.00
13.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 815.01 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.17% vs -2.03% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 106.13 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 23.54% vs -15.49% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 182.47 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -5.69% vs -1.06% in Dec 2024

Annual - Interest
Interest 3.40 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -47.53% vs -25.77% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.69%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024